How high a bar to change neoadjuvant therapy for triple-negative breast cancer?

被引：0
|
作者：
Kuritzky, Benjamin [1 ]
Sikov, William M. [2 ,3 ]
机构：
[1] Rhode Isl Hosp, Hematol Oncol Fellowship Program, Providence, RI 02903 USA
[2] Women & Infants Hosp Rhode Isl, Program Womens Oncol, Providence, RI 02905 USA
[3] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2015年 / 4卷 / 04期
关键词：
bevacizumab; carboplatin; neoadjuvant chemotherapy; triple-negative breast cancer; PATHOLOGICAL COMPLETE RESPONSE; PHASE-3; TRIAL; BEVACIZUMAB; CHEMOTHERAPY; CARBOPLATIN; SURVIVAL;
D O I：
10.2217/CER.15.29
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：293 / 296
页数：4
相关论文
共 50 条
  • [1] Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
    Moore-Smith, Lakisha
    Forero-Torres, Andres
    Stringer-Reasor, Erica
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 773 - +
  • [2] Efficacy of neoadjuvant systemic carboplatin therapy in triple-negative breast cancer
    Thomssen, Christoph
    Schuler, Kathleen
    Bauer, Marcus
    Reinhardt, Kristin
    Strauss, Hans-Gerorg
    Vetter, Martina
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [3] The prognosis of effectiveness neoadjuvant therapy in patients with triple-negative breast cancer
    Vyzhigina, B.
    [J]. BREAST, 2019, 44 : S67 - S67
  • [4] Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Yam, Clinton
    Yen, Er-Yen
    Chang, Jeffrey T.
    Bassett, Roland L., Jr.
    Alatrash, Gheath
    Garber, Haven
    Huo, Lei
    Yang, Fei
    Philips, Anne, V
    Ding, Qing-Qing
    Lim, Bora
    Ueno, Naoto T.
    Kannan, Kasthuri
    Sun, Xiangjie
    Sun, Baohua
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    White, Jason B.
    Ravenberg, Elizabeth
    Seth, Sahil
    Guerriero, Jennifer L.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer K.
    Wargo, Jennifer A.
    Hortobagyi, Gabriel N.
    Futreal, Andrew
    Wistuba, Ignacio I.
    Sun, Ryan
    Moulder, Stacy L.
    Mittendorf, Elizabeth A.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5365 - 5375
  • [5] Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Silva, Diogo
    Mesquita, Alexandra
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2022, 16
  • [6] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [7] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [8] Neoadjuvant platin and bevacizumab in triple-negative breast cancer
    Kern, P.
    Otterbach, F.
    Kolberg, H. C.
    Pott, D.
    Kalisch, A.
    Kimmig, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Biomarkers for Personalized Neoadjuvant Therapy in Triple-Negative Breast Cancer: Moving Forward
    Rauch, Gaiane M.
    [J]. RADIOLOGY, 2024, 312 (03)
  • [10] Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Hess, Kenneth
    Santiago, Lumarie
    Lane, Deanna L.
    Thompson, Alastair M.
    Moulder, Stacy L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Leung, Jessica W. T.
    Symmans, W. Fraser
    Valero, Vicente
    Ravenberg, Elizabeth E.
    White, Jason B.
    Yang, Wei Tse
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
12345